Orserdu

Active Ingredient(s): Elacestrant Dihydrochloride
FDA Approved: * January 27, 2023
Pharm Company: * STEMLINE THERAP
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Orserdu 86 mg Oral Tablet, Film Coated
NDC: 72187-0101
Labeler:
Stemline Therapeutics, Inc.
Orserdu 345 mg Oral Tablet, Film Coated
NDC: 72187-0102
Labeler:
Stemline Therapeutics, Inc.